News / Media

Briotech, UW Bothell, & PennState Present HPV & Oropharyngeal Cancer Research

Results: HOCl treatment contact times generally and quickly produced >99.99% reduction in infectivity of HPV16 and HPV18, comparable to the efficacy of 0.87% sodium hypochlorite. Exposure of cel...

PennState Presents the Effectiveness of BrioHOCl™ Against HPV — Geneva, Switzerland

Dr. Craig Meyers, PennState Cancer Institute, presents an HPV abstract on the results of efficacy testing of BrioHOCl™ against high-risk HPV16 and HPV18 at the 5th Annual ICPIC.